Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
X. Zhang (Beijing, China). The clinical dynamic changes and prognosis analysis in patients with cryptogenic organizing pneumonia. Eur Respir J 2011; 38: Suppl. 55, 3744

Member's Comments

No comment yet.

Related content which might interest you: Clinical analysis of 25 subjects with biopsy-proven cryptogenic organizing pneumonia Source: Annual Congress 2007 - Clinical aspects of idiopathic pulmonary fibrosis Year: 2007 Clinical features of cryptogenic organizing pneumonia in a Chilean population Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 The role of inflammatory parameters in the diagnosis and management of patients with community-acquired pneumonia Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Clinical features of cryptogenic organising pneumonia in Chinese population Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease Year: 2009 Clinical features of cryptogenic and secondary organizing pneumonia in Iceland Source: Eur Respir J 2006; 28: Suppl. 50, 99s Year: 2006 The clinical characteristics of non-resolving or slow-resolving pneumonia associated with the pathology of an organizing pneumonia Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008 Prognostic determinants in IPF patients with the histological features of usual interstitial pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 526s Year: 2001 Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Early outcomes in CAP: clinical stability, clinical failure and nonresolving pneumonia Source: Eur Respir Monogr 2014; 63: 205-218 Year: 2014 Another view on the prediction of outcomes in patients with community-acquired pneumonia Source: Eur Respir J 2011; 38: 992-993 Year: 2011 Another view on the prediction of outcomes in patients with community-acquired pneumonia Source: Eur Respir J 2011; 38: 991-992 Year: 2011 I like clinical pulmonary infection scores to define the role of clinical evaluation to diagnose pneumonia and ventilator-associated pneumonia Source: Annual Congress 2009 - Diagnosis of ventilator-associated pneumonia: challenge the dogmas! Year: 2009 Clinical features and outcome of patients with acute exacerbation of interstitial pneumonia associated with collagen vascular disease Source: Annual Congress 2010 - Clinical aspects in pulmonary fibrosis Year: 2010 Recognising poor prognosis community-acquired pneumonia in young adults with simple clinical measurements Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006 Correlation of renal impairment with biochemical and radiological findings, and clinical outcome in COVID-19 pneumonia patients Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 An unbalanced inflammatory response on admission impacts clinical stability in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Comparing clinical features of cases with bronchiectasis on acute and stable term Source: Eur Respir J 2005; 26: Suppl. 49, 305s Year: 2005 Clinical features of COVID-19 pneumonia in elderly patients Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011